tiprankstipranks
Advertisement
Advertisement
Minerva Neurosciences Updates Governance Following 2026 Shareholder Meeting
PremiumCompany AnnouncementsMinerva Neurosciences Updates Governance Following 2026 Shareholder Meeting
3M ago
Minerva Neurosciences Launches ATM Offering to Fund Trial
Premium
Company Announcements
Minerva Neurosciences Launches ATM Offering to Fund Trial
4M ago
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
Premium
Company Announcements
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
4M ago
Minerva Neurosciences Appoints New Chief Business Officer, Counsel
PremiumCompany AnnouncementsMinerva Neurosciences Appoints New Chief Business Officer, Counsel
5M ago
Minerva appoints Jim O’Connor as chief business officer
Premium
The Fly
Minerva appoints Jim O’Connor as chief business officer
5M ago
Minerva screens first patient in roluperidone trial
Premium
The Fly
Minerva screens first patient in roluperidone trial
6M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
PremiumMarket NewsVanguard Total Stock Market ETF (VTI) Daily Snapshot—3/11/26
6M ago
Minerva reports Q4 adjusted EPS (64c) vs. (53c) last year
Premium
The Fly
Minerva reports Q4 adjusted EPS (64c) vs. (53c) last year
6M ago
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100